Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new term from nonalcoholic fatty liver disease (NAFLD) and is a positive diagnosis based on histopathology, imaging, or blood biomarkers. MAFLD is one of the common causes of liver dysfunction worldwide, likely due to the increase in...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasoppokakorn, Thaninee, Pitisuttithum, Panyavee, Treeprasertsuk, Sombat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666366/
https://www.ncbi.nlm.nih.gov/pubmed/34966657
http://dx.doi.org/10.14218/JCTH.2021.00189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666366/
https://www.ncbi.nlm.nih.gov/pubmed/34966657
http://dx.doi.org/10.14218/JCTH.2021.00189

Ejemplares similares